IL37 and rheumatoid arthritis: Although some scientists suggested that IL-23/IL-17 axis plays important role in RA pathogenesis and should be considered for the development of targeted therapies 22, our results indicate that IL-41 may be even more important for RA pathogenesis and treatment outcomes.